EClinCloud and Pure Global Form Strategic Partnership to Reshape End-to-End Clinical Research and Global Access with AI

EClinCloud and Pure Global announce a strategic partnership.
Building on both companies' strengths in AI technology capabilities and global resource networks, this partnership deeply integrates EClinCloud's intelligent integrated cloud platform with Pure Global's AI-enabled global regulatory compliance and market access solutions. Together, the two companies will build an end-to-end digital solution spanning clinical trial design, data capture, operations management, and endpoint assessment through to global regulatory submissions, overseas regulatory consulting, distribution channel alignment, and commercialization—helping pharmaceutical and medical device companies overcome the dual barriers of R&D efficiency and overseas compliance and accelerate the globalization of innovative therapies.
Proprietary Technology Synergy: Ecosystem-Level Integration of Two Intelligent AI Platforms
EClinCloud empowers global clinical research with AI technology. Its in-house AI-driven integrated clinical research cloud platform (including interconnected systems such as eCOA/CTMS/eTMF/EDC/RTSM/IRC/RM) uses intelligent risk alerts, dynamic data modeling, and predictive analytics to improve clinical trial success rates and substantially shorten R&D cycles.
Meanwhile, leveraging products and services built to international standards, EClinCloud has gained extensive practical experience in global regulatory compliance and data standardization, established deep collaborations with leading domestic and international pharmaceutical companies and CROs, and accumulated over 1,000 successful cases, including multiple large-scale international Phase III clinical studies.
Pure Global, as one of the very few technology service providers worldwide certified to BSI ISO 13485:2016, leverages its in-house GRIP Global Regulatory Intelligence Platform and AI-enabled global compliance and market-access solutions to provide global pharmaceutical and medical device companies with multi-country registration and market-access, European and US clinical, and full-lifecycle compliance services.
Through
AI and big data, PureGlobal can track regulatory developments across countries in real time, intelligently analyze compliance pathways, and optimize multi-country registration strategies, greatly improving the efficiency and success rate of companies' international registrations. At the same time, relying on intelligent collaboration tools such as AI translation and AI medical writing, it greatly helps companies rapidly generate high-quality compliance documents, improve global submission efficiency, and accelerate the international rollout of innovative products.
A Strong Alliance: Top Global Teams Joining Forces
EClinCloud has top domestic and international clinical and AI experts, forming an end-to-end innovation capability spanning "clinical insights—system development—data intelligence."
·
★
The core team is led by senior leaders from well-known multinational companies in the industry, and the company brings together talented professionals from top 50 global universities such as Tsinghua University, Peking University, the University of Chicago, Northwestern University, and Boston University;
★
The medical team consists of professionals from major global pharmaceutical companies such as Pfizer and Novo Nordisk, with deep professional expertise and forward-looking perspectives in drug research and development, clinical research, regulatory science, and related fields;
★
The technical team brings together top technical talent from technology giants such as IBM and Oracle, proficient in big data processing, cloud computing, and artificial intelligence, forming a multidisciplinary talent pipeline in leading global clinical research and digital technology to accelerate the digital transformation of global clinical research.
Pure Global (普瑞纯证) has a leading global team of regulatory and AI experts.
★
Many core team members hold degrees from leading international universities such as Carnegie Mellon University, forming a diverse and specialized team that includes former FDA reviewers, regulatory experts who previously worked at CE notified bodies and COFEPRIS (Mexico's regulatory authority), a former Emergo CEO, a former Vice President of Siemens Healthcare, and multiple compliance experts from global healthcare companies such as Cactus Life Science and Covidien;
★
Many of its technical team members are AI specialists from Google and Citadel Securities with deep expertise in AI algorithms and big data processing, as well as years of in-depth research and practice in AI + healthcare, dedicated to advancing the deep application of artificial intelligence technology in global regulatory compliance and market access.
Through this collaboration, the talent strengths of both sides will be deeply integrated to broaden
"professional depth" and "global reach," setting a new industry benchmark of "intelligence-driven efficiency." EClinCloud's AI technology transforms clinical trials into a "data-driven" model, substantially improving R&D efficiency and data quality; meanwhile, PureGlobal leverages its AI-enabled global regulatory compliance and market-access solutions and localized expert network to ensure these data outcomes are rapidly and efficiently converted into passports to market access across countries.
EClinCloud Founder
and CEO Dr. Qin Long said:
"Collaborative innovation in AI technology and the strategic alliance between both parties will advance clinical research into an era of 'intelligent global connectivity,' underpinned by the deep integration of both sides' technologies, data, and global resource networks."
PureGlobal Founder
& CEO Meng Zhu emphasized:
"The core challenge in global medical innovation lies in achieving the optimal balance between speed and compliance. Traditional clinical trials and global registration processes often involve long timelines and high costs, and AI technology is reshaping this landscape."
About EClinCloud
EClinCloud is a leading AI company in the clinical research industry. Leveraging AI, it builds an integrated intelligent clinical cloud platform and endpoint assessment technologies to provide global pharmaceutical companies and research institutions with technology products such as eCOA, CTMS, eTMF, EDC, RTSM, IRC, and RM, as well as scale management, linguistic validation, rater training, and data quality analysis services, creating efficient and precise digital solutions. Relying on AI predictive models and an intelligent data platform, it dynamically assesses and helps improve drug clinical trial success rates, helping shorten drug and medical device development cycles to benefit patients.
About Purui Chunzheng
Pure Global
is a global, AI-enabled life sciences service provider dedicated to offering one-stop global market access solutions for medical device and pharmaceutical companies. Leveraging its proprietary GRIP global regulatory intelligence platform, along with AI-driven translation, medical writing, and intelligent compliance tools, Pure Global substantially improves companies' efficiency in multi-country registration, overseas clinical trials, regulatory compliance, and market entry. The company has established a service network across 32 countries worldwide, operates 19 local subsidiaries, and has built a team of local regulatory experts covering North America, South America, Europe, Asia, the Middle East, and Australia. In addition to accurately interpreting national regulations and optimizing registration pathways, Pure Global also assists companies with compliance consulting, sales channel connections, and multi-country market analysis, helping clients complete product registrations more efficiently and accelerate commercialization worldwide, bringing higher-quality medical solutions to patients globally.


